逍遥散证宏观指标范围研究

Investigation of the Scope of Macroscopic Indications Related with the Syndrome Represented by Xiaoyao Powder

目的 制定逍遥散证临床观察量表。方法 依据逍遥散古今文献、专家咨询等分析选取的与逍遥散证相关的宏观指征 ,进行统计学处理。临床收集 5 8例患者 (2 5种疾病 ) ,设立阳性对照药组和逍遥散治疗药组 ,观察与逍遥散证相关的宏观指征、抑郁自评量表 (SDS)和焦虑自评量表 (SAS)等的改变。结果 逍遥散对 2 7个宏观指征有不同程度的改善 ,且随年龄段和性别不同而有所差异。结论 逍遥散证的发生与焦虑等情志有关 。

Objective To establish the clinical observation scales for the syndrome represented by Xiaoyao Powder (XP). Methods The macroscopic indications related with the syndrome represented by XP were collected according to the XP literature in both ancient and modern times and the analyses made by experts; the macroscopic indications were then processed by statistical methods. 58 Clinical cases (involving 25 diseases) were divided into the positive control group and XP-treating group in order to investigate the effects of XP on the macroscopic indications related with the syndrome represented by XP, on SDS and on SAS. Results XP could improve 27 macroscopic indications to different degree and the effects of XP were age and sex dependent. Conclusion The syndrome represented by XP is related with emotions, for example, anxiety; the syndrome can correspond to a common status of many diseases.